T. Hata

Development of a novel drug delivery system, time-controlled explosion system (TES). IV. In vivo drug release behavior.

R. Ibuki, S. Ueda, A. Kawamura, 1994, Journal of drug targeting.

Bone-specific delivery and sustained release of diclofenac, a non-steroidal anti-inflammatory drug, via bisphosphonic prodrug based on the Osteotropic Drug Delivery System (ODDS).

H. Hirabayashi, Y. Tokunaga, T. Takahashi, 2001, Journal of controlled release : official journal of the Controlled Release Society.

Osteotropic drug delivery system (ODDS) based on bisphosphonic prodrug. I.v. effects of osteotropic estradiol on bone mineral density and uterine weight in ovariectomized rats.

Y. Tokunaga, T. Takahashi, S. Kimura, 1998, Journal of drug targeting.

Osteotropic drug delivery system (ODDS) based on bisphosphonic prodrug. V. Biological disposition and targeting characteristics of osteotropic estradiol.

Y. Tokunaga, T. Takahashi, S. Kimura, 1997, Biological & pharmaceutical bulletin.

Physicochemical Characterization of Bisphosphonic Carboxyfluorescein for Osteotropic Drug Delivery

S. Murata, Y. Tokunaga, T. Takahashi, 1996, The Journal of pharmacy and pharmacology.

Osteotropic drug delivery system (ODDS) based on bisphosphonic prodrug. III: Pharmacokinetics and targeting characteristics of osteotropic carboxyfluorescein.

Y. Tokunaga, T. Sawamoto, T. Takahashi, 1996, Journal of drug targeting.

Osteotropic drug delivery system (ODDS) based on bisphosphonic prodrug. I: synthesis and in vivo characterization of osteotropic carboxyfluorescein.

Y. Tokunaga, T. Hirose, A. Kagayama, 1995, Journal of drug targeting.

Development of a novel drug delivery system, time-controlled explosion system (TES): V. Animal pharmacodynamic study and human bioavailability study

S. Ueda, A. Kagayama, S. Tamura, 1994 .

Development of a novel drug release system, time-controlled explosion system (TES). I. Concept and design.

S. Ueda, T. Hata, T. Hata, 1994, Journal of drug targeting.